65 related articles for article (PubMed ID: 3375986)
1. Volumetrical and morphological responses of human laryngeal squamous cell carcinoma xenografts treated with fractionated irradiation.
Hoogenhout J; Jerusalem CR; van Gasteren H; Kal HB
Strahlenther Onkol; 1988 May; 164(5):300-6. PubMed ID: 3375986
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
3. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
4. Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
Agemy L; Harmelin A; Waks T; Leibovitch I; Rabin T; Pfeffer MR; Eshhar Z
Prostate; 2008 Apr; 68(5):530-9. PubMed ID: 18247403
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
6. Protracted exposure radiosensitization of experimental human malignant glioma.
Williams JA; Williams JR; Yuan X; Dillehay LE
Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
8. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
9. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation.
Durkovský J; Sevcíková L; Miklánková M
Neoplasma; 1981; 28(5):599-609. PubMed ID: 7312078
[TBL] [Abstract][Full Text] [Related]
10. Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line.
Redpath JL; Hyden EC; Sun C
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):681-5. PubMed ID: 7790254
[TBL] [Abstract][Full Text] [Related]
11. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
13. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
Wang CC; Nakfoor BM; Spiro IJ; Martins P
Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
[TBL] [Abstract][Full Text] [Related]
14. [Procedure and results of combined radiation and surgical treatment of laryngeal cancer patients].
Seniukov MV; Goldobenko GV; Mardynskiĭ IuS; Lushnikov EF; Skoropad IuD
Med Radiol (Mosk); 1983 Sep; 28(9):17-23. PubMed ID: 6621278
[TBL] [Abstract][Full Text] [Related]
15. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
18. [A change in the concentration of DNA during radiation therapy of cancer of the larynx].
Krasnova VG
Vopr Onkol; 1975; 21(7):28-32. PubMed ID: 1216786
[TBL] [Abstract][Full Text] [Related]
19. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
